Which has grown faster, CSBR or FBIO?

Over the past five years, CSBR grew revenue faster — CSBR at a 7.25% CAGR versus FBIO at 5.39%.

Is CSBR or FBIO more profitable?

FBIO runs the higher net margin — CSBR at -1.87% versus FBIO at 163.32%.

How have CSBR and FBIO total returns compared?

Over the past 10 years, CSBR delivered 12.07% and FBIO delivered -26.29% annualized total return. Past performance doesn't predict future results.

Champions Oncology, Inc. (CSBR) vs Fortress Biotech, Inc. (FBIO)

A side-by-side comparison of Champions Oncology, Inc. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CSBR

Champions Oncology, Inc.

$70M

$5.06HealthcareDelayed quote: Oct 6, 2026, 12:36 PM EDT

FBIO

Fortress Biotech, Inc.

$68M

$2.06HealthcareDelayed quote: Oct 6, 2026, 12:37 PM EDT

Total return — CSBR vs FBIO

growth of $100 · dividends reinvested · last 10y

CSBR +208.7% (+11.9%/yr)FBIO -95.1% (-26.1%/yr)CSBR compounded faster over this window

Log scale — wide-divergence pair

CSBR FBIO

CSBR vs FBIO: by the numbers

•CSBR is the larger company ($70M vs $68M market cap).
•FBIO is profitable (163.32% net margin) while CSBR runs a net loss (-1.87%).
•CSBR grew revenue faster over the past five years (7.25% vs 5.39% CAGR).

Metrics side by side

Valuation

Metric	CSBR	FBIO
P/E ratio	N/A	0.77
Forward P/E	50.60	N/A
P/S ratio	1.16	1.00
P/B ratio	18.06	0.42
EV / EBITDA	264.31	N/A
FCF yield	N/A	183.86%

Profitability

Metric	CSBR	FBIO
Gross margin	49.30%	62.53%
Operating margin	-1.72%	-111.00%
Net margin	-1.87%	163.32%
ROE	-29.15%	68.12%
ROIC	-6.75%	-10.85%

Growth (annualized)

Metric	CSBR	FBIO
Revenue CAGR (5Y)	7.25%	5.39%
Total return CAGR (5Y)	-13.07%	-46.06%

Frequently asked

Which has grown faster, CSBR or FBIO?: Over the past five years, CSBR grew revenue faster — CSBR at a 7.25% CAGR versus FBIO at 5.39%.
Is CSBR or FBIO more profitable?: FBIO runs the higher net margin — CSBR at -1.87% versus FBIO at 163.32%.
How have CSBR and FBIO total returns compared?: Over the past 10 years, CSBR delivered 12.07% and FBIO delivered -26.29% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CSBR analysis Full FBIO analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Champions Oncology ROE Fortress Biotech ROE Champions Oncology operating margin Fortress Biotech operating margin Champions Oncology revenue growth Fortress Biotech revenue growth Champions Oncology free cash flow Fortress Biotech free cash flow

Champions Oncology & Fortress Biotech appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.